Recent Progress in Polymer Therapeutics as Nanomedicines - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 112

19. Bisht, S. and A. Maitra, Dextran-doxorubicin/chitosan nanoparticles for
solid tumor therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol,
2009. 1 (4): p. 415-425.
20. Baldwin, A.D. and K.L. Kiick, Polysaccharide-modified synthetic
polymeric biomaterials. Biopolymers, 2010. 94 (1): p. 128-140.
21. Grzelinski, M., et al., RNA interference-mediated gene silencing of
pleiotrophin through polyethylenimine-complexed small interfering
RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Human Gene Ther, 2006. 17 (7): p. 751-766.
22. Schaff ert, D. and E. Wagner, Gene therapy progress and prospects:
synthetic polymer-based systems. Gene Ther, 2008. 15 (16): p. 1131-
1138.
23. Danhauser-Riedl, S., et al., Phase I clinical and pharmacokinetic trial of
dextran conjugated doxorubicin (AD-70, DOX-OXD). Invest New Drugs,
1993. 11 (2-3): p. 187-195.
24. Singh, R.S., G.K. Saini, and J.F. Kennedy, Pullulan: microbial sources,
production and applications. Carbohyr Polym, 2008. 73 : p. 515-531.
25. Leather, T.D., Production and applications of pullulan. Appl. Microbiol
Biotechnol, 2003. 62 : p. 468-473.
26. Kim, S., et al., Insulinotropic activity of sulfonylurea/pullulan conjugate
in rat islet microcapsule. Biomaterials, 2003. 24 (26): p. 4843-4851.
27. Clementi, C., et al., Dendritic Poly(ethylene glycol) bearing Paclitaxel
and Alendronate for targeting bone neoplasms. Mol Pharm, 2011. 8 (4):
p. 1063-1072.
28. Vasey, P.A., et al., Phase I clinical and pharmacokinetic study of PK1
[ N -(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first
member of a new class of chemotherapeutic agents-drug-polymer
conjugates. Cancer Research Campaign Phase I/II Committee . Clin
Cancer Res , 1999. 5 (1): p. 83-94.
29. Teodorescu, M. and K. Matyjaszewski, Atom transfer radical
polymerization of (meth)acrylamides. Macromolecules, 1999. 32 : p.
4826-4831.
30. Teodorescu, M. and K. Matyjaszewski, Controlled polymerization of
(meth)acrylamides by atom transfer radical polymerization. Macrol.
Rapid Commun., 2000. 21 : p. 190-194.
31. Scales, C.W., et al., Direct, controlled synthesis of the nonimmunogenic,
hydrophilic polymer, poly( N -(2-hydroxypropyl)methacrylamide) via
RAFT in aqueous media . Biomacromolecules , 2005. 6 (4): p. 1846-
1850.
32. Segal, E., et al., Targeting angiogenesis-dependent calcified neoplasms
using combined polymer therapeutics. PLoS One, 2009. 4 (4): p. e5233.